Amyotrophic Lateral Sclerosis Market Size was USD 490 Million in 2021
  • Reads 2
  • Votes 0
  • Parts 1
  • Time <5 mins
  • Reads 2
  • Votes 0
  • Parts 1
  • Time <5 mins
Ongoing, First published Apr 19, 2023
According to DelveInsight, Amyotrophic Lateral Sclerosis Market was USD 490 million in 2021, and it is estimated to grow during the study period of 2019-2032. Modern therapeutic strategies comprise of neuroprotective treatment focused on antiglutamatergic, antioxidant, antiapoptotic, and anti-inflammatory molecules. Drugs approved for the treatment of Amyotrophic Lateral Sclerosis are IV Radicava (Mitsubishi Tanabe Pharma), Rilutek/Riluzole) (Sanofi/Covis), Exservan (Aquestive Therapeutics), and Tiglutik/ Teglutik (ITF Pharma).
For more information Visit here:-https://www.delveinsight.com/report-store/amyotrophic-lateral-sclerosis-market-forecast?utm_source=youtube&utm_medium=video&utm_campaign=ypr
All Rights Reserved
Sign up to add Amyotrophic Lateral Sclerosis Market Size was USD 490 Million in 2021 to your library and receive updates
or
#17businessmarketing
Content Guidelines
You may also like
Slide 1 of 1
The Virus Within: The Unranked (Book 4) cover

The Virus Within: The Unranked (Book 4)

50 parts Complete

Season 4 of The Virus Within Trinity is familiar with zombies, being one herself, but when strange zombies start appearing, she realizes that the world she knew might be changing yet again. When a dangerous set of scientific notes are discovered, Trinity and her friends don't realize anything is wrong until a frantic radio call comes in. Unaware of the notes, they race to the south and struggle to determine where the strange zombies came from. The zombies are unlike any ranks previously seen, and they aren't as predictable. Some have new tricks hidden up sleeves, forcing any Stronghold they encounter to quickly adapt to the new challenge or risk being overrun. Secrets never remain hidden, and zombie apocalypses never make life easy.